Toyota|$18.03 (¥2,881)+1.30%▲ (in JPY terms)
Sony|$22.65 (¥3,619)-1.36%▼ (in JPY terms)
SoftBank|$52.03 (¥8,315)-3.67%▼ (in JPY terms)
MUFG|$19.63 (¥3,137)+2.99%▲ (in JPY terms)
Keyence|$504.55 (¥80,630)+2.92%▲ (in JPY terms)
Nintendo|$46.66 (¥7,457)+0.42%▲ (in JPY terms)
NTT|$0.92 (¥148)-0.07%▼ (in JPY terms)
Takeda|$29.71 (¥4,748)-2.10%▼ (in JPY terms)
Tokyo Electron|$381.09 (¥60,900)+13.39%▲ (in JPY terms)
Recruit|$68.33 (¥10,920)+0.69%▲ (in JPY terms)
ITOCHU|$11.63 (¥1,859)+0.05%▲ (in JPY terms)
Honda|$9.36 (¥1,497)+7.89%▲ (in JPY terms)
Shin-Etsu|$48.85 (¥7,806)+4.46%▲ (in JPY terms)
Tokio Marine|$44.42 (¥7,098)+0.74%▲ (in JPY terms)
Fast Retailing|$490.72 (¥78,420)-1.58%▼ (in JPY terms)
Toyota|$18.03 (¥2,881)+1.30%▲ (in JPY terms)
Sony|$22.65 (¥3,619)-1.36%▼ (in JPY terms)
SoftBank|$52.03 (¥8,315)-3.67%▼ (in JPY terms)
MUFG|$19.63 (¥3,137)+2.99%▲ (in JPY terms)
Keyence|$504.55 (¥80,630)+2.92%▲ (in JPY terms)
Nintendo|$46.66 (¥7,457)+0.42%▲ (in JPY terms)
NTT|$0.92 (¥148)-0.07%▼ (in JPY terms)
Takeda|$29.71 (¥4,748)-2.10%▼ (in JPY terms)
Tokyo Electron|$381.09 (¥60,900)+13.39%▲ (in JPY terms)
Recruit|$68.33 (¥10,920)+0.69%▲ (in JPY terms)
ITOCHU|$11.63 (¥1,859)+0.05%▲ (in JPY terms)
Honda|$9.36 (¥1,497)+7.89%▲ (in JPY terms)
Shin-Etsu|$48.85 (¥7,806)+4.46%▲ (in JPY terms)
Tokio Marine|$44.42 (¥7,098)+0.74%▲ (in JPY terms)
Fast Retailing|$490.72 (¥78,420)-1.58%▼ (in JPY terms)

DAIICHI SANKYO COMPANY,LIMITED

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approval of Datroway® (datopotamab deruxtecan) for the first-line treatment of triple-negative breast cancer in the United States will open in a new window.”

by

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approv … 続きを読む

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial changes to the Enhertu® (trastuzumab deruxtecan) drug for HER2-positive early-stage breast cancer in the United States will open in a new window.”

by

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial … 続きを読む

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for the dried attenuated live measles, mumps, and rubella combined vaccine "Mimlit® for subcutaneous injection" (176.8KB). (PDF file will open in a new window.)”

by

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for t … 続きを読む

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revision of the product supply plan and revisions to the consolidated earnings forecast for the full fiscal year ending March 2026 will be displayed in a new window.”

by

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revis … 続きを読む

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab deruxtecan (T-DXd/DS-8201) for HER2-positive breast cancer following neoadjuvant therapy in the United States (242.9 KB) PDF file opens in a new window.”

by

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab d … 続きを読む

Contact